1.
Karolina Ollik, Kamil Harenza, Mateusz Taranowicz, et al. NEW DISEASE-MODIFYING THERAPIES IN ALZHEIMER’S DISEASE: A CLINICAL REVIEW OF LECANEMAB AND DONANEMAB. IJITSS. 2026;2(1(49). doi:10.31435/ijitss.1(49).2026.4885